Guggenheim Maintains Buy on Eli Lilly, Raises Price Target to $1030
Portfolio Pulse from Benzinga Newsdesk
Guggenheim analyst Seamus Fernandez maintains a Buy rating on Eli Lilly (NYSE:LLY) and raises the price target from $884 to $1030.
August 16, 2024 | 5:09 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Guggenheim analyst Seamus Fernandez maintains a Buy rating on Eli Lilly and raises the price target from $884 to $1030.
The raised price target and maintained Buy rating from a reputable analyst at Guggenheim is likely to positively impact Eli Lilly's stock price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100